Lipitension is the coexistence of hypertension and dyslipidemia in a patient.
This book is a concise guide to both conditions.
Divided into two sections, consisting of 20 chapters each, this book addresses hypertension in the first half. Beginning with a history, epidemiology, risk factors and etiology of the condition, subsequent chapters cover different forms of hypertension, from gestational hypertension to hypertension in infants, women and the elderly.
The second section covers dyslipidemia, a condition where an abnormal amount of cholesterol or fat is found in the blood. Topics range from discussion on the use of statins to dietary changes and lipid abnormalities after kidney transplant. Each chapter in both sections is followed by clinical case scenarios and questions to test understanding.
Lipitension incorporates all the latest guidelines from various accredited bodies, including the American Heart Association (AHA) and National Institute for Clinical Excellence (NICE), ensuring current, authoritative, practical advice for all cardiology practitioners.
• Practical, authoritative and current guide to hypertension and dyslipidemia
• Clinical cases and test questions with every chapter
• Includes the latest AHA and NICE guidelines
Hypertension • History of Hypertension • Epidemiology, Risk Factors and Etiology of HTN • Secondary HTN– Causes & Evaluation • HTN – Whom to treat? • Essential HTN-Evidence Based Therapeutic Choices • Resistant HTN – Etiology & Management • Gestational HTN – Who’s at risk & why? • Salt & Dietary changes in HTN • ACE inhibitors & ARB’s – Why are they the drugs of choice? • Hypertensive Urgencies – Ignorance at your own peril • Chronic Kidney Disease & HTN – The Inseparable Siblings • HTN Management in Pregnancy & Post-partum period • HTN – Perioperative Management • Goals in HTN – Should we be aggressive or laidback? • Renal Transplantation & HTN • HTN in Infants • HTN in Women • HTN In Elderly • Exercise in HTN – What, why, how much? • Ambulatory BP Monitoring Dyslipidemia • When and whom to screen for Dyslipidemia? • Statins – Why are they wonder drugs? • Statins and Chronic kidney disease • Lipoprotein classification & role in Atherosclerosis • Diabetic Dyslipidemia • Secondary causes of Dyslipidemia • Treatment of Dyslipidemia • Atherosclerosis & Dyslipidemia in children • Hypertriglyceridemia – How to approach & when to treat • NAFLD • Thyroid & Dyslipidemia • Fibrates – Should they stay or go off-shelf? • Nephrotic syndrome & lipid abnormalities • Primary disorders of LDL cholesterol metabolism • Lipid lowering with diet • HDL – The elusive good cholesterol • Lipid abnormalities after Renal Transplantation • Cholesterol Lowering Clinical Trials • Cholesterol Lowering after ACS • Lipid abnormalities in chronic kidney disease
Jasvinder Singh Anand
Senior Consultant in Internal Medicine, Medanta -The Medicity, Gurgaon, Haryana, India